Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Poison control center reference in OTC labeling should be retained -- NDAC member.

This article was originally published in The Rose Sheet

Executive Summary

POISON CONTROL CENTERS REFERENCE ON OTC LABELING RECOMMENDED by FDA Nonprescription Drugs Advisory Committee member Cage Johnson, MD, University of Southern California, as an item that should be retained in FDA's Feb. 27 proposed OTC drug label reform regulation. Speaking at NDAC's July 14 meeting in Bethesda, Md, Johnson said he "would strongly support the inclusion of `Poison Control Center' as a source of assistance" on OTC labels "rather than the somewhat nebulous `get medical help'" message suggested in the agency's proposed rule ("The Rose Sheet" March 3, pp. 11-13). The Poison Control Center is "the source of the most topical, most accurate information in cases of accidental overdose," Johnson maintained.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel